These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37595101)

  • 1. Viewing Then Doing?: Problem-Solving Court Coordinators' Perceptions of Medications for Opioid Use Disorders from a Nationally Representative Survey in the United States.
    Smith LR; Faragó F; Blue T; Witte JC; Gordon MS; Taxman FS
    Subst Use Misuse; 2023; 58(13):1780-1788. PubMed ID: 37595101
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators.
    Farago F; Blue TR; Smith LR; Witte JC; Gordon M; Taxman FS
    J Drug Issues; 2023 Apr; 53(2):296-320. PubMed ID: 38179102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.
    Andraka-Christou B; Clark MH; Atkins DN; Del Pozo B
    Subst Abus; 2022; 43(1):425-432. PubMed ID: 34236297
    [No Abstract]   [Full Text] [Related]  

  • 4. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B; Atkins D
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
    O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whose opinion matters about medications for opioid use disorder? A cross-sectional survey of social norms among court staff.
    Andraka-Christou B; Atkins DN
    Subst Abus; 2021; 42(4):735-750. PubMed ID: 33284059
    [No Abstract]   [Full Text] [Related]  

  • 7. Court personnel attitudes towards medication-assisted treatment: A state-wide survey.
    Andraka-Christou B; Gabriel M; Madeira J; Silverman RD
    J Subst Abuse Treat; 2019 Sep; 104():72-82. PubMed ID: 31370988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staff.
    Andraka-Christou B; Atkins D; Madeira J; Silverman RD
    Drug Alcohol Rev; 2020 Jul; 39(5):583-587. PubMed ID: 32394525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug court utilization of medications for opioid use disorder in high opioid mortality communities.
    Marlowe DB; Theiss DS; Ostlie EM; Carnevale J
    J Subst Abuse Treat; 2022 Oct; 141():108850. PubMed ID: 35931014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.
    O'Reilly LM; Schwartz K; Brown SA; Dir A; Gillenwater L; Adams Z; Zapolski T; Hulvershorn LA; Aalsma M
    Subst Abuse Treat Prev Policy; 2024 Jun; 19(1):32. PubMed ID: 38907286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic Procedures: Adapting Problem-Solving Court (PSC) Operations and Treatment Protocols During COVID-19.
    Smith LR; Faragó F; Witte JC; Blue T; Gordon MS; Taxman FS
    J Drug Issues; 2023 Jul; 53(3):490-498. PubMed ID: 38603347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S; Sun L; Vakkalanka JP
    Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder.
    Andraka-Christou B; Nguyen T; Bradford DW; Simon K
    J Subst Abuse Treat; 2020 Mar; 110():49-58. PubMed ID: 31952628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to medications for opioid use disorder in the court system: provider availability, provider "trustworthiness," and cost.
    Ahmed FZ; Andraka-Christou B; Clark MH; Totaram R; Atkins DN; Del Pozo B
    Health Justice; 2022 Jul; 10(1):24. PubMed ID: 35895179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problem-Solving Court Staff Preferences for Educational Videos about Medications for Opioid Use Disorder.
    Andraka-Christou B; Asi YM; Totaram R; Matusow H
    Subst Use Misuse; 2023; 58(12):1550-1559. PubMed ID: 37462200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers.
    Pivovarova E; Taxman FS; Boland AK; Smelson DA; Lemon SC; Friedmann PD
    J Subst Use Addict Treat; 2023 Apr; 147():208950. PubMed ID: 36804347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences.
    Brown AR; Walters JE; Harmer B; Cates L; Jones AE
    J Subst Use Addict Treat; 2023 Dec; 155():209153. PubMed ID: 37673286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes Regarding Medications for Opioid Use Disorder Among Peer Recovery Coaches.
    Suzuki J; Loguidice F; Martin B
    J Addict Med; 2023 Jan-Feb 01; 17(1):101-103. PubMed ID: 35914085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.